Standard

Effect of Hyperglycemia on Gene Expression during Early Organogenesis in Mice. / Zhao, Jing; Hakvoort, Theodorus B. M.; Willemsen, A. Marcel et al.

In: PLoS ONE, Vol. 11, No. 7, 2016, p. e0158035.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

APA

Vancouver

Zhao J, Hakvoort TBM, Willemsen AM, Jongejan A, Sokolovic M, Bradley EJ et al. Effect of Hyperglycemia on Gene Expression during Early Organogenesis in Mice. PLoS ONE. 2016;11(7):e0158035. doi: 10.1371/journal.pone.0158035

Author

Zhao, Jing ; Hakvoort, Theodorus B. M. ; Willemsen, A. Marcel et al. / Effect of Hyperglycemia on Gene Expression during Early Organogenesis in Mice. In: PLoS ONE. 2016 ; Vol. 11, No. 7. pp. e0158035.

BibTeX

@article{f921f2ffbf954ca0b8a2ee4b65313ce4,
title = "Effect of Hyperglycemia on Gene Expression during Early Organogenesis in Mice",
abstract = "Cardiovascular and neural malformations are common sequels of diabetic pregnancies, but the underlying molecular mechanisms remain unknown. We hypothesized that maternal hyperglycemia would affect the embryos most shortly after the glucose-sensitive time window at embryonic day (ED) 7.5 in mice. Mice were made diabetic with streptozotocin, treated with slow-release insulin implants and mated. Pregnancy aggravated hyperglycemia. Gene expression profiles were determined in ED8.5 and ED9.5 embryos from diabetic and control mice using Serial Analysis of Gene Expression and deep sequencing. Maternal hyperglycemia induced differential regulation of 1,024 and 2,148 unique functional genes on ED8.5 and ED9.5, respectively, mostly in downward direction. Pathway analysis showed that ED8.5 embryos suffered mainly from impaired cell proliferation, and ED9.5 embryos from impaired cytoskeletal remodeling and oxidative phosphorylation (all P ≤ E-5). A query of the Mouse Genome Database showed that 20-25% of the differentially expressed genes were caused by cardiovascular and/or neural malformations, if deficient. Despite high glucose levels in embryos with maternal hyperglycemia and a ~150-fold higher rate of ATP production from glycolysis than from oxidative phosphorylation on ED9.5, ATP production from both glycolysis and oxidative phosphorylation was reduced to ~70% of controls, implying a shortage of energy production in hyperglycemic embryos. Maternal hyperglycemia suppressed cell proliferation during gastrulation and cytoskeletal remodeling during early organogenesis. 20-25% of the genes that were differentially regulated by hyperglycemia were associated with relevant congenital malformations. Unexpectedly, maternal hyperglycemia also endangered the energy supply of the embryo by suppressing its glycolytic capacity",
author = "Jing Zhao and Hakvoort, {Theodorus B. M.} and Willemsen, {A. Marcel} and Aldo Jongejan and Milka Sokolovic and Bradley, {Edward J.} and {de Boer}, {Vincent C. J.} and Frank Baas and {van Kampen}, {Antoine H. C.} and Lamers, {Wouter H.}",
year = "2016",
doi = "10.1371/journal.pone.0158035",
language = "English",
volume = "11",
pages = "e0158035",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

RIS

TY - JOUR

T1 - Effect of Hyperglycemia on Gene Expression during Early Organogenesis in Mice

AU - Zhao, Jing

AU - Hakvoort, Theodorus B. M.

AU - Willemsen, A. Marcel

AU - Jongejan, Aldo

AU - Sokolovic, Milka

AU - Bradley, Edward J.

AU - de Boer, Vincent C. J.

AU - Baas, Frank

AU - van Kampen, Antoine H. C.

AU - Lamers, Wouter H.

PY - 2016

Y1 - 2016

N2 - Cardiovascular and neural malformations are common sequels of diabetic pregnancies, but the underlying molecular mechanisms remain unknown. We hypothesized that maternal hyperglycemia would affect the embryos most shortly after the glucose-sensitive time window at embryonic day (ED) 7.5 in mice. Mice were made diabetic with streptozotocin, treated with slow-release insulin implants and mated. Pregnancy aggravated hyperglycemia. Gene expression profiles were determined in ED8.5 and ED9.5 embryos from diabetic and control mice using Serial Analysis of Gene Expression and deep sequencing. Maternal hyperglycemia induced differential regulation of 1,024 and 2,148 unique functional genes on ED8.5 and ED9.5, respectively, mostly in downward direction. Pathway analysis showed that ED8.5 embryos suffered mainly from impaired cell proliferation, and ED9.5 embryos from impaired cytoskeletal remodeling and oxidative phosphorylation (all P ≤ E-5). A query of the Mouse Genome Database showed that 20-25% of the differentially expressed genes were caused by cardiovascular and/or neural malformations, if deficient. Despite high glucose levels in embryos with maternal hyperglycemia and a ~150-fold higher rate of ATP production from glycolysis than from oxidative phosphorylation on ED9.5, ATP production from both glycolysis and oxidative phosphorylation was reduced to ~70% of controls, implying a shortage of energy production in hyperglycemic embryos. Maternal hyperglycemia suppressed cell proliferation during gastrulation and cytoskeletal remodeling during early organogenesis. 20-25% of the genes that were differentially regulated by hyperglycemia were associated with relevant congenital malformations. Unexpectedly, maternal hyperglycemia also endangered the energy supply of the embryo by suppressing its glycolytic capacity

AB - Cardiovascular and neural malformations are common sequels of diabetic pregnancies, but the underlying molecular mechanisms remain unknown. We hypothesized that maternal hyperglycemia would affect the embryos most shortly after the glucose-sensitive time window at embryonic day (ED) 7.5 in mice. Mice were made diabetic with streptozotocin, treated with slow-release insulin implants and mated. Pregnancy aggravated hyperglycemia. Gene expression profiles were determined in ED8.5 and ED9.5 embryos from diabetic and control mice using Serial Analysis of Gene Expression and deep sequencing. Maternal hyperglycemia induced differential regulation of 1,024 and 2,148 unique functional genes on ED8.5 and ED9.5, respectively, mostly in downward direction. Pathway analysis showed that ED8.5 embryos suffered mainly from impaired cell proliferation, and ED9.5 embryos from impaired cytoskeletal remodeling and oxidative phosphorylation (all P ≤ E-5). A query of the Mouse Genome Database showed that 20-25% of the differentially expressed genes were caused by cardiovascular and/or neural malformations, if deficient. Despite high glucose levels in embryos with maternal hyperglycemia and a ~150-fold higher rate of ATP production from glycolysis than from oxidative phosphorylation on ED9.5, ATP production from both glycolysis and oxidative phosphorylation was reduced to ~70% of controls, implying a shortage of energy production in hyperglycemic embryos. Maternal hyperglycemia suppressed cell proliferation during gastrulation and cytoskeletal remodeling during early organogenesis. 20-25% of the genes that were differentially regulated by hyperglycemia were associated with relevant congenital malformations. Unexpectedly, maternal hyperglycemia also endangered the energy supply of the embryo by suppressing its glycolytic capacity

U2 - 10.1371/journal.pone.0158035

DO - 10.1371/journal.pone.0158035

M3 - Article

C2 - 27433804

VL - 11

SP - e0158035

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 7

ER -

ID: 2951769